Table 1 Maximum likelihood estimates of hazard ratios and cure rates for E1684 and E1690
From: Bayesian methods in clinical trials: a Bayesian analysis of ECOG trials E1684 and E1690
Endpoint | Study | Hazard ratio | Cure rate | |
|---|---|---|---|---|
(95% CI) | (95% CI) | |||
OBS | IFN | |||
RFS | E1684 | 1.43 | 0.17 | 0.35 |
(1.08, 1.89) | (0.06, 0.33) | (0.28, 0.43) | ||
E1690 | 1.28 | 0.32 | 0.44 | |
(1.00, 1.65) | (0.24, 0.40) | (0.37, 0.50) | ||
OS | E1684 | 1.32 | 0.25 | 0.40 |
(0.98, 1.78) | (0.12, 0.41) | (0.32, 0.49) | ||
E1690 | 1.00 | 0.49 | 0.47 | |
(0.75, 1.33) | (0.36, 0.60) | (0.37, 0.56) | ||